What are the precautions with proton pump inhibitor use for reflux disease?

被引：2

作者：

Mospan, Cortney M. ^{[1
,2
]}

机构：

[1] E Tennessee State Univ, Bill Gatton Coll Pharm, Pharm Practice, Johnson City, TN 37614 USA

[2] Univ Charitable Pharm, Columbus, OH USA

来源：

JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2015年 / 28卷 / 12期

关键词：

gastroesophageal reflux disease; proton pump inhibitor; comorbidities; older adults; clopidogrel; fractures; THERAPY; SAFETY;

D O I：

10.1097/01.JAA.0000473372.47749.16

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Gastroesophageal reflux disease (GERD) affects 10% to 20% of the western world's population. Current treatment guidelines recommend proton pump inhibitors (PPIs) as first-line therapy. Although PPIs cause mild adverse reactions, they pose risks, particularly for older adults with comorbidities.

引用

页码：23 / 26

页数：3

共 50 条

[21] The rising trend of on-demand and intermittent proton pump inhibitor therapy in gastroesophageal reflux disease: What is the evidence?
Bautista, Jimmy M.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : S112 - S114
[22] Persistent Reflux Symptoms in the Proton Pump Inhibitor Era: The Changing Face of Gastroesophageal Reflux Disease
Dellon, Evan S.
Shaheen, Nicholas J.
GASTROENTEROLOGY, 2010, 139 (01) : 7 - U30
[23] Gastroesophageal Reflux Disease or Proton Pump Inhibitor Use? A Controversy Over the Association of Nontuberculous Mycobacterial Pulmonary Disease Response
Lee, Hyun
Kim, Youlim
Yoon, Jai Hoon
Choi, Hayoung
CHEST, 2023, 163 (03) : E148 - E148
[24] Treatment of proton pump inhibitor-resistant patients with gastroesophageal reflux disease
Yoshikazu Kinoshita
Hideaki Kazumori
Shunji Ishihara
Journal of Gastroenterology, 2006, 41 : 286 - 287
[25] Combination Treatment With Proton Pump Inhibitor Plus Prokinetic for Gastroesophageal Reflux Disease
Tariq, Muhammad Ali
Ahmed, Bilal
JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2022, 28 (01) : 164 - 164
[26] Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease
Hillman, L.
Yadlapati, R.
Whitsett, M.
Thuluvath, A. J.
Berendsen, M. A.
Pandolfino, J. E.
DISEASES OF THE ESOPHAGUS, 2017, 30 (09) : 1 - 14
[27] Gastro-Oesophageal Reflux Disease Beyond Proton Pump Inhibitor Therapy
Hershcovici, Tiberiu
Fass, Ronnie
DRUGS, 2011, 71 (18) : 2381 - 2389
[28] A review of medical therapy for proton pump inhibitor nonresponsive gastroesophageal reflux disease
Hillman, L.
Yadlapati, R.
Thuluvath, A. J.
Berendsen, M. A.
Pandolfino, J. E.
DISEASES OF THE ESOPHAGUS, 2017, 30 (09): : 1 - 15
[29] Treatment of proton pump inhibitor-resistant patients with gastroesophageal reflux disease
Kinoshita, Y
Kazumori, H
Ishihara, S
JOURNAL OF GASTROENTEROLOGY, 2006, 41 (03) : 286 - 287
[30] Therapeutic choices in reflux disease: Defining the criteria for selecting a proton pump inhibitor
Freston, JW
AMERICAN JOURNAL OF MEDICINE, 2004, 117 : 14S - 22S

← 1 2 3 4 5 →